Cargando…
Paeonol promotes Opa1-mediated mitochondrial fusion via activating the CK2α-Stat3 pathway in diabetic cardiomyopathy
Diabetes disrupts mitochondrial function and often results in diabetic cardiomyopathy (DCM). Paeonol is a bioactive compound that has been reported to have pharmacological potential for cardiac and mitochondrial protection. This study aims to explore the effects of paeonol on mitochondrial disordere...
Autores principales: | Liu, Chaoyang, Han, Yuehu, Gu, Xiaoming, Li, Man, Du, Yanyan, Feng, Na, Li, Juan, Zhang, Shumiao, Maslov, Leonid N., Wang, Guoen, Pei, Jianming, Fu, Feng, Ding, Mingge |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8385203/ https://www.ncbi.nlm.nih.gov/pubmed/34418601 http://dx.doi.org/10.1016/j.redox.2021.102098 |
Ejemplares similares
-
Paeonol protects against doxorubicin-induced cardiotoxicity by promoting Mfn2-mediated mitochondrial fusion through activating the PKCε-Stat3 pathway
por: Ding, Mingge, et al.
Publicado: (2022) -
BNP protects against diabetic cardiomyopathy by promoting Opa1-mediated mitochondrial fusion via activating the PKG-STAT3 pathway
por: Chang, Pan, et al.
Publicado: (2023) -
Mfn2-mediated mitochondrial fusion alleviates doxorubicin-induced cardiotoxicity with enhancing its anticancer activity through metabolic switch
por: Ding, Mingge, et al.
Publicado: (2022) -
Corrigendum to “Mfn2-mediated mitochondrial fusion alleviates doxorubicin-induced cardiotoxicity with enhancing its anticancer activity through metabolic switch” [Redox Biol. 52 (2022) 1–16/102311]
por: Ding, Mingge, et al.
Publicado: (2022) -
OPA1, a molecular regulator of dilated cardiomyopathy
por: Chen, Jiaqi, et al.
Publicado: (2023)